Pranlukast, a cysteinyl leukotriene type 1 receptor antagonist, attenuates the progression but not the onset of silica-induced pulmonary fibrosis in mice (Q83540813)
Jump to navigation
Jump to search
scientific article published on 27 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pranlukast, a cysteinyl leukotriene type 1 receptor antagonist, attenuates the progression but not the onset of silica-induced pulmonary fibrosis in mice |
scientific article published on 27 February 2012 |
Statements
Pranlukast, a cysteinyl leukotriene type 1 receptor antagonist, attenuates the progression but not the onset of silica-induced pulmonary fibrosis in mice (English)
Chiko Shimbori
Naotaka Shiota
27 February 2012